Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock
Open accessThe DOI matches its Crossref record; 531 of the 531 references it cites were found in a registry or an index.
Abstract
SUMMARY: Bacterial sepsis and septic shock result from the overproduction of inflammatory mediators as a consequence of the interaction of the immune system with bacteria and bacterial wall constituents in the body. Bacterial cell wall constituents such as lipopolysaccharide, peptidoglycans, and lipoteichoic acid are particularly responsible for the deleterious effects of bacteria. These constituents interact in the body with a large number of proteins and receptors, and this interaction determines the eventual inflammatory effect of the compounds. Within the circulation bacterial constituents interact with proteins such as plasma lipoproteins and lipopolysaccharide binding protein. The interaction of the bacterial constituents with receptors on the surface of mononuclear cells is mainly responsible for the induction of proinflammatory mediators by the bacterial constituents. The role of individual receptors such as the toll-like receptors and CD14 in the induction of proinflammatory cytokines and adhesion molecules is discussed in detail. In addition, the roles of a number of other receptors that bind bacterial compounds such as scavenger receptors and their modulating role in inflammation are described. Finally, the therapies for the treatment of bacterial sepsis and septic shock are discussed in relation to the action of the aforementioned receptors and proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · cited 5×
“In addition, TLR3 recognizes viral double-stranded RNA dsRNA, TLR5 recognizes bacterial flagellin, and TLR9 recognizes bacterial CpG DNA (references are given in Table 2).”
BackgroundInfluentialEfficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J.-L., Laterre, P.-F., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,132
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. (1997) · Nature · doi:10.1038/41131 · Cited by 5,590
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,987
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
Hayashi, F., Smith, K. D., Ozinsky, A., Hawn, T. R., Yi, E. C., Goodlett, D. R., Eng, J. K., Akira, S., Underhill, D. M., & Aderem, A. (2001) · Nature · doi:10.1038/35074106 · Cited by 3,601
Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K., & Akira, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3749 · Cited by 3,374
Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80119-3 · Cited by 3,362
Physiological functions of glucocorticoids in stress and their relation to pharmacological actions
MUNCK, A., GUYRE, P. M., & HOLBROOK, N. J. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-1-25 · Cited by 3,083 · cited 1×
“They inhibit a number of inflammatory processes, such as leukocyte infiltration and cytokine production, and have a positive effect on cardiac output by a blockade of NO synthesis (48, 371).”
BackgroundBeutler, B., Milsark, I. W., & Cerami, A. C. (1985) · Science · doi:10.1126/science.3895437 · Cited by 2,352
MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4
Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., & Kimoto, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1777 · Cited by 2,185
Ozinsky, A., Underhill, D. M., Fontenot, J. D., Hajjar, A. M., Smith, K. D., Wilson, C. B., Schroeder, L., & Aderem, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250476497 · Cited by 2,085
Unresponsiveness of MyD88-Deficient Mice to Endotoxin
Kawai, T., Adachi, O., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80086-2 · Cited by 2,076
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., & Krieger, M. (1996) · Science · doi:10.1126/science.271.5248.518 · Cited by 2,026
Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdörfer, B., Giese, T., Endres, S., & Hartmann, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4531 · Cited by 1,935
A New Method for the Extraction of R Lipopolysaccharides
Galanos, C., Lüderitz, O., & Westphal, O. (1969) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1969.tb00601.x · Cited by 1,859
Rooijen, N. V., & Sanders, A. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90012-4 · Cited by 1,779
Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2
Schwandner, R., Dziarski, R., Wesche, H., Rothe, M., & Kirschning, C. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17406 · Cited by 1,704 · cited 2×
“LPS from the LTA-induced activation through TLR2 was observed in overexpression experiments (478).”
BackgroundPattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus
Kurt-Jones, E. A., Popova, L., Kwinn, L., Haynes, L. M., Jones, L. P., Tripp, R. A., Walsh, E. E., Freeman, M. W., Golenbock, D. T., Anderson, L. J., et al. (2000) · Nature Immunology · doi:10.1038/80833 · Cited by 1,683
Pfeffer, K., Matsuyama, T., Kündig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Krönke, M., & Mak, T. W. (1993) · Cell · doi:10.1016/0092-8674(93)90134-c · Cited by 1,677 · cited 1×
“small amounts of live bacteria or yeast (343, 422).”
BackgroundStructure and Function of Lipopolysaccharide Binding Protein
Schumann, R. R., Leong, S. R., Flaggs, G. W., Gray, P. W., Wright, S. D., Mathison, J. C., Tobias, P. S., & Ulevitch, R. J. (1990) · Science · doi:10.1126/science.2402637 · Cited by 1,672
Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like Receptors
Brightbill, H. D., Libraty, D. H., Krutzik, S. R., Yang, R.-B., Belisle, J. T., Bleharski, J. R., Maitland, M., Norgard, M. V., Plevy, S. E., Smale, S. T., et al. (1999) · Science · doi:10.1126/science.285.5428.732 · Cited by 1,661
Bacterial endotoxin: molecular relationships of structure to activity and function
Rietschel, E. T., Kirikae, T., Schade, F. U., Mamat, U., Schmidt, G., Loppnow, H., Ulmer, A. J., Zähringer, U., Seydel, U., Di Padova, F., et al. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.2.8119492 · Cited by 1,607
Ohashi, K., Burkart, V., Flohé, S., & Kolb, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.558 · Cited by 1,606
The Liver: Biology and Pathobiology.
(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-5-690_3 · Cited by 1,590
Pathogenetic Mechanisms of Septic Shock
Epstein, F. H., & Parrillo, J. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282008 · Cited by 1,548
Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)
Qureshi, S. T., Larivière, L., Leveque, G., Clermont, S., Moore, K. J., Gros, P., & Malo, D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.4.615 · Cited by 1,525
Novel Signal Transduction Pathway Utilized by Extracellular HSP70
Asea, A., Rehli, M., Kabingu, E., Boch, J. A., Baré, O., Auron, P. E., Stevenson, M. A., & Calderwood, S. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200497200 · Cited by 1,510
Bone, R. C., Fisher, C. J., Clemmer, T. P., Slotman, G. J., Metz, C. A., Balk, R. A., & The Methylprednisolone Severe Sepsis Study Group (1987) · New England Journal of Medicine · doi:10.1056/nejm198709103171101 · Cited by 1,440
Navarre, W. W., & Schneewind, O. (1999) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.63.1.174-229.1999 · Cited by 1,391
The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens
Underhill, D. M., Ozinsky, A., Hajjar, A. M., Stevens, A., Wilson, C. B., Bassetti, M., & Aderem, A. (1999) · Nature · doi:10.1038/44605 · Cited by 1,368
Bone, R. C. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-6-457 · Cited by 1,368
Toll-like receptors control activation of adaptive immune responses
Schnare, M., Barton, G. M., Holt, A. C., Takeda, K., Akira, S., & Medzhitov, R. (2001) · Nature Immunology · doi:10.1038/ni712 · Cited by 1,365
LeVine, A. M., Kurak, K. E., Wright, J. R., Watford, W. T., Bruno, M. D., Ross, G. F., Whitsett, J. A., & Korfhagen, T. R. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.20.2.3303 · Cited by 1,273
Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein
Fisher, C. J., Agosti, J. M., Opal, S. M., Lowry, S. F., Balk, R. A., Sadoff, J. C., Abraham, E., Schein, R. M. H., & Benjamin, E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342603 · Cited by 1,241
Yoshimura, A., Lien, E., Ingalls, R. R., Tuomanen, E., Dziarski, R., & Golenbock, D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.1 · Cited by 1,234
Discrimination of bacterial lipoproteins by Toll-like receptor 6
Takeuchi, O., Kawai, T., Mühlradt, P. F., Morr, M., Radolf, J. D., Zychlinsky, A., Takeda, K., & Akira, S. (2001) · International Immunology · doi:10.1093/intimm/13.7.933 · Cited by 1,232
Raetz, C. R. H. (1990) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.59.070190.001021 · Cited by 1,230
A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection
Suzuki, H., Kurihara, Y., Takeya, M., Kamada, N., Kataoka, M., Jishage, K., Ueda, O., Sakaguchi, H., Higashi, T., Suzuki, T., et al. (1997) · Nature · doi:10.1038/386292a0 · Cited by 1,224
Self-citationToll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling
Yang, R.-B., Mark, M. R., Gray, A., Huang, A., Xie, M. H., Zhang, M., Goddard, A., Wood, W. I., Gurney, A. L., & Godowski, P. J. (1998) · Nature · doi:10.1038/26239 · Cited by 1,205
Krieger, M., & Krieger, J. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.003125 · Cited by 1,160
Hirschfeld, M., Ma, Y., Weis, J. H., Vogel, S. N., & Weis, J. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.618 · Cited by 1,153
Muzio, M., Bosisio, D., Polentarutti, N., D’amico, G., Stoppacciaro, A., Mancinelli, R., van’t Veer, C., Penton-Rol, G., Ruco, L. P., Allavena, P., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5998 · Cited by 1,060
Takeuchi, O., Hoshino, K., & Akira, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5392 · Cited by 1,048
Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a Mutant Escherichia coli
Ziegler, E. J., McCutchan, J. A., Fierer, J., Glauser, M. P., Sadoff, J. C., Douglas, H., & Braude, A. I. (1982) · New England Journal of Medicine · doi:10.1056/nejm198211113072001 · Cited by 1,046
Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils
Kodama, T., Freeman, M., Rohrer, L., Zabrecky, J., Matsudaira, P., & Krieger, M. (1990) · Nature · doi:10.1038/343531a0 · Cited by 1,041
Steel, D. M., & Whitehead, A. S. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90138-4 · Cited by 1,025
Essential role of MD-2 in LPS responsiveness and TLR4 distribution
Nagai, Y., Akashi, S., Nagafuku, M., Ogata, M., Iwakura, Y., Akira, S., Kitamura, T., Kosugi, A., Kimoto, M., & Miyake, K. (2002) · Nature Immunology · doi:10.1038/ni809 · Cited by 1,020
Treating Patients with Severe Sepsis
Wheeler, A. P., & Bernard, G. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400307 · Cited by 992
HSP70 as Endogenous Stimulus of the Toll/Interleukin-1 Receptor Signal Pathway
Vabulas, R. M., Ahmad-Nejad, P., Ghose, S., Kirschning, C. J., Issels, R. D., & Wagner, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111204200 · Cited by 948
Toll-like Receptor 2 Functions as a Pattern Recognition Receptor for Diverse Bacterial Products
Lien, E., Sellati, T. J., Yoshimura, A., Flo, T. H., Rawadi, G., Finberg, R. W., Carroll, J. D., Espevik, T., Ingalls, R. R., Radolf, J. D., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33419 · Cited by 918
Biologically active products of stimulated liver macrophages (Kupffer cells)
DECKER, K. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb19222.x · Cited by 904
Opal, S. M., Fisher, C. J., Dhainaut, J.-F. A., Vincent, J.-L., Brase, R., Lowry, S. F., Sadoff, J. C., Slotman, G. J., Levy, H., Balk, R. A., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00010 · Cited by 865
Pugin, J., Schürer-Maly, C. C., Leturcq, D., Moriarty, A., Ulevitch, R. J., & Tobias, P. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2744 · Cited by 831
Apolipoprotein E: Structure-Function Relationships
Weisgraber, K. H. (1994) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60642-7 · Cited by 830
Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages
Underhill, D. M., Ozinsky, A., Smith, K. D., & Aderem, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14459 · Cited by 827
GPI-Anchored Cell-Surface Molecules Complexed to Protein Tyrosine Kinases
Štefanová, I., Hořejši, V., Ansotegui, I. J., Knapp, W., & Stockinger, H. (1991) · Science · doi:10.1126/science.1719635 · Cited by 826
Human Toll-Like Receptors Mediate Cellular Activation by Mycobacterium tuberculosis
Means, T. K., Wang, S., Lien, E., Yoshimura, A., Golenbock, D. T., & Fenton, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3920 · Cited by 804 · cited 1×
“TLR4 Gram-negative bacteria LPS (221, 428, 441) Gram-positive bacteria LTA (514) Mycobacteria Heat-sensitive compound (357) Chlamydia pneumoniae Heat shock protein 60 (55) Respiratory syncytial virus F protein (282) Treponema brennaborense Glycolipids (471) Human protein Heat shock protein 60 (396) Human protein Heat…”
BackgroundGlucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates
Boumpas, D. T., Chrousos, G. P., Wilder, R. L., Cupps, T. R., & Balow, J. E. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-12-199312150-00007 · Cited by 778
Nomura, F., Akashi, S., Sakao, Y., Sato, S., Kawai, T., Matsumoto, M., Nakanishi, K., Kimoto, M., Miyake, K., Takeda, K., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.7.3476 · Cited by 764
Lugtenberg, B., & Van Alphen, L. (1983) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(83)90014-x · Cited by 759
Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide
Kirschning, C. J., Wesche, H., Merrill Ayres, T., & Rothe, M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2091 · Cited by 753
Greenman, R. L. (1991) · JAMA · doi:10.1001/jama.266.8.1097 · Cited by 752
Cario, E., Rosenberg, I. M., Brandwein, S. L., Beck, P. L., Reinecker, H.-C., & Podolsky, D. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.966 · Cited by 751
Killing of gram-negative bacteria by lactoferrin and lysozyme.
Ellison, R. T., & Giehl, T. J. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115407 · Cited by 746
Bals, R., Wang, X., Zasloff, M., & Wilson, J. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9541 · Cited by 746
Haziot, A., Ferrero, E., Köntgen, F., Hijiya, N., Yamamoto, S., Silver, J., Stewart, C. L., & Goyert, S. M. (1996) · Immunity · doi:10.1016/s1074-7613(00)80254-x · Cited by 743
Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism
Werts, C., Tapping, R. I., Mathison, J. C., Chuang, T.-H., Kravchenko, V., Saint Girons, I., Haake, D. A., Godowski, P. J., Hayashi, F., Ozinsky, A., et al. (2001) · Nature Immunology · doi:10.1038/86354 · Cited by 733
Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide
Lien, E., Means, T. K., Heine, H., Yoshimura, A., Kusumoto, S., Fukase, K., Fenton, M. J., Oikawa, M., Qureshi, N., Monks, B., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8541 · Cited by 727
Glauser, M. P., Zanetti, G., Baumgartner, J.-D., & Cohen, J. (1991) · The Lancet · doi:10.1016/0140-6736(91)91452-z · Cited by 716
THE BIOCHEMISTRY AND GENETICS OF CAPSULAR POLYSACCHARIDE PRODUCTION IN BACTERIA
Roberts, I. S. (1996) · Annual Review of Microbiology · doi:10.1146/annurev.micro.50.1.285 · Cited by 701
Mahley, R. W., & Ji, Z.-S. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33334-4 · Cited by 693
Soluble CD14 participates in the response of cells to lipopolysaccharide.
Frey, E. A., Miller, D. S., Jahr, T. G., Sundan, A., Bazil, V, Espevik, T., Finlay, B. B., & Wright, S. D. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1665 · Cited by 682
Hirschfeld, M., Kirschning, C. J., Schwandner, R., Wesche, H., Weis, J. H., Wooten, R. M., & Weis, J. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2382 · Cited by 657
Lipopolysaccharide Is in Close Proximity to Each of the Proteins in Its Membrane Receptor Complex
da Silva Correia, J., Soldau, K., Christen, U., Tobias, P. S., & Ulevitch, R. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009164200 · Cited by 649
Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature
Cronin, L., Cook, D. J., Carlet, J., Heyland, D. K., King, D. B. M., Lansang, M. A. D., & Fisher, Jr. (1995) · Critical Care Medicine · doi:10.1097/00003246-199508000-00019 · Cited by 622
Characterization of tumor necrosis factor-deficient mice
Marino, M. W., Dunn, A., Grail, D., Inglese, M., Noguchi, Y., Richards, E., Jungbluth, A., Wada, H., Moore, M., Williamson, B., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8093 · Cited by 622
Regulation of Toll-Like Receptors in Human Monocytes and Dendritic Cells
Visintin, A., Mazzoni, A., Spitzer, J. H., Wyllie, D. H., Dower, S. K., & Segal, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.249 · Cited by 612
Zhang, F. X., Kirschning, C. J., Mancinelli, R., Xu, X.-P., Jin, Y., Faure, E., Mantovani, A., Rothe, M., Muzio, M., & Arditi, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7611 · Cited by 595
CD14: Cell surface receptor and differentiation marker
Ziegler-Heitbrock, H. W. L., & Ulevitch, R. J. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90212-4 · Cited by 584
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein
Larrick, J. W., Hirata, M., Balint, R. F., Lee, J., Zhong, J., & Wright, S. C. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1291-1297.1995 · Cited by 573
Takeuchi, O., Kaufmann, A., Grote, K., Kawai, T., Hoshino, K., Morr, M., Mühlradt, P. F., & Akira, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.554 · Cited by 569
Faure, E., Equils, O., Sieling, P. A., Thomas, L., Zhang, F. X., Kirschning, C. J., Polentarutti, N., Muzio, M., & Arditi, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11058 · Cited by 560
Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum.
Tobias, P. S., Soldau, K., & Ulevitch, R. J. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.3.777 · Cited by 541
Recognition and plasma clearance of endotoxin by scavenger receptors
Hampton, R. Y., Golenbock, D. T., Penman, M., Krieger, M., & Raetz, C. R. H. (1991) · Nature · doi:10.1038/352342a0 · Cited by 524
Elomaa, O., Kangas, M., Sahlberg, C., Tuukkanen, J., Sormunen, R., Liakka, A., Thesleff, I., Kraal, G., & Tryggvason, K. (1995) · Cell · doi:10.1016/0092-8674(95)90514-6 · Cited by 514
The role of complement in inflammation and phagocytosis
Frank, M. M., & Fries, L. F. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90009-i · Cited by 503
Bowie, A., & O'Neill, L. A. J. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.4.508 · Cited by 495
Steroid controversy in sepsis and septic shock: A meta-analysis
Lefering, R., & Neugebauer, E. A. M. (1995) · Critical Care Medicine · doi:10.1097/00003246-199507000-00021 · Cited by 485
In vivo protection against endotoxin by plasma high density lipoprotein.
Levine, D. M., Parker, T. S., Donnelly, T. M., Walsh, A., & Rubin, A. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.12040 · Cited by 485
Cell surface heparan sulfate proteoglycans.
Yanagishita, M., & Hascall, V. C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50108-9 · Cited by 474
Hajjar, A. M., O’Mahony, D. S., Ozinsky, A., Underhill, D. M., Aderem, A., Klebanoff, S. J., & Wilson, C. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.15 · Cited by 465
Weiss, J., Elsbach, P., Olsson, I., & Odeberg, H. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40872-6 · Cited by 451
Wright, S. D., Weitz, J. I., Huang, A. J., Levin, S. M., Silverstein, S. C., & Loike, J. D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.20.7734 · Cited by 444
Wurfel, M. M., Kunitake, S. T., Lichenstein, H., Kane, J. P., & Wright, S. D. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.1025 · Cited by 442 · cited 1×
“very-low-density lipoprotein (VLDL), or HDL (414, 569, 600).”
Means, T. K., Lien, E., Yoshimura, A., Wang, S., Golenbock, D. T., & Fenton, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6748 · Cited by 431
Poltorak, A., Ricciardi-Castagnoli, P., Citterio, S., & Beutler, B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040565397 · Cited by 429
Mathison, J. C., & Ulevitch, R. J. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.123.5.2133 · Cited by 422
Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes.
Golenbock, D. T., Hampton, R. Y., Qureshi, N., Takayama, K., & Raetz, C. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55023-7 · Cited by 416
Levin, M., Quint, P. A., Goldstein, B., Barton, P., Bradley, J. S., Shemie, S., Yeh, T., Kim, S. S., Cafaro, D. P., Scannon, P. J., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02712-4 · Cited by 411
Bulut, Y., Faure, E., Thomas, L., Karahashi, H., Michelsen, K. S., Equils, O., Morrison, S. G., Morrison, R. P., & Arditi, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1435 · Cited by 405
Wright, S. D., & Jong, M. T. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.6.1876 · Cited by 405
Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo.
Feingold, K. R., & Grunfeld, C. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113046 · Cited by 403
Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9.
Chuang, T., & Ulevitch, R. J. (2000) · PubMed · Cited by 399
Perera, P.-Y., Mayadas, T. N., Takeuchi, O., Akira, S., Zaks-Zilberman, M., Goyert, S. M., & Vogel, S. N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.574 · Cited by 391
Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia.
Pajkrt, D., Doran, J. E., Koster, F., Lerch, P. G., Arnet, B., van der Poll, T., ten Cate, J. W., & van Deventer, S. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.1601 · Cited by 390
Poltorak, A., Smirnova, I., He, X., Liu, M.-Y., Van Huffel, C., Birdwell, D., Alejos, E., Silva, M., Du, X., Thompson, P., et al. (1998) · Blood Cells, Molecules, and Diseases · doi:10.1006/bcmd.1998.0201 · Cited by 387
Elshourbagy, N. A., Liao, W. S., Mahley, R. W., & Taylor, J. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.203 · Cited by 376
Rietschel, E. T., & Brade, H. (1992) · Scientific American · doi:10.1038/scientificamerican0892-54 · Cited by 375
Dunne, D. W., Resnick, D., Greenberg, J., Krieger, M., & Joiner, K. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.5.1863 · Cited by 365
Lactoferrin is a lipid A-binding protein
Appelmelk, B. J., An, Y. Q., Geerts, M., Thijs, B. G., de Boer, H. A., MacLaren, D. M., de Graaff, J., & Nuijens, J. H. (1994) · Infection and Immunity · doi:10.1128/iai.62.6.2628-2632.1994 · Cited by 362
Electrodialysis of Lipopolysaccharides and Their Conversion to Uniform Salt Forms
GALANOS, C., & LÜDERITZ, O. (1975) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1975.tb04172.x · Cited by 359
Hardonk, M., Dijkhuis, F., Hulstaert, C., & Koudstaal, J. (1992) · Journal of Leukocyte Biology · doi:10.1002/jlb.52.3.296 · Cited by 358
De Kimpe, S. J., Kengatharan, M., Thiemermann, C., & Vane, J. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10359 · Cited by 357
Wright, S. D., Tobias, P. S., Ulevitch, R. J., & Ramos, R. A. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.4.1231 · Cited by 354
Tobias, P. S., Soldau, K., & Ulevitch, R. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81700-8 · Cited by 347
Feingold, K., Staprans, I., Memon, R., Moser, A., Shigenaga, J., Doerrler, W., Dinarello, C., & Grunfeld, C. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41334-3 · Cited by 346
Lipopolysaccharide-binding protein is required to combat a murine Gram-negative bacterial infection
Jack, R. S., Fan, X., Bernheiden, M., Rune, G., Ehlers, M., Weber, A., Kirsch, G., Mentel, R., Fürll, B., Freudenberg, M., et al. (1997) · Nature · doi:10.1038/39622 · Cited by 345
LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria.
Lamping, N., Dettmer, R., Schröder, N. W., Pfeil, D., Hallatschek, W., Burger, R., & Schumann, R. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2338 · Cited by 344
Seki, S., Habu, Y., Kawamura, T., Takeda, K., Dobashi, H., Ohkawa, T., & Hiraide, H. (2000) · Immunological Reviews · doi:10.1034/j.1600-0528.2002.017404.x · Cited by 343
The molecular pathogenesis of endotoxic shock and organ failure
Karima, R., Matsumoto, S., Higashi, H., & Matsushima, K. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01430-0 · Cited by 340
Lactoferrin: A Multifunctional Glycoprotein Involved in the Modulation of the Inflammatory Process
Baveye, S., Elass, E., Mazurier, J., Spik, G., & Legrand, D. (1999) · cclm · doi:10.1515/cclm.1999.049 · Cited by 338
Freudenberg, M. A., Keppler, D., & Galanos, C. (1986) · Infection and Immunity · doi:10.1128/iai.51.3.891-895.1986 · Cited by 333
Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures.
Morrison, D., & Leive, L. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41574-3 · Cited by 331
Studies of endotoxin-induced decrease in lipoprotein lipase activity.
Kawakami, M., & Cerami, A. (1981) · The Journal of experimental medicine · doi:10.1084/jem.154.3.631 · Cited by 327
THE STRUCTURAL BASIS OF T CELL ACTIVATION BY SUPERANTIGENS
Li, H., Llera, A. S., Malchiodi, E. L., & Mariuzza, R. A. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.435 · Cited by 324
CYTOKINES AND ANTICYTOKINES IN THE PATHOGENESIS OF SEPSIS
van der Poll, T., & van Deventer, S. J. H. (1999) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70083-0 · Cited by 323
Jiang, Q., Akashi, S., Miyake, K., & Petty, H. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.3541 · Cited by 320
Harris, H. W., Grunfeld, C., Feingold, K. R., & Rapp, J. H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114765 · Cited by 320
Gram-positive Organisms and Sepsis
Bone, R. C. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.1.26 · Cited by 315
Effects of endotoxin and cytokines on lipid metabolism
Hardardóttir, I., Grünfeld, C., & Feingold, K. R. (1994) · Current Opinion in Lipidology · doi:10.1097/00041433-199405030-00008 · Cited by 304
Staphylococcal Cell Wall: Morphogenesis and Fatal Variations in the Presence of Penicillin
Giesbrecht, P., Kersten, T., Maidhof, H., & Wecke, J. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.4.1371-1414.1998 · Cited by 304
Augmentation of Innate Host Defense by Expression of a Cathelicidin Antimicrobial Peptide
Bals, R., Weiner, D. J., Moscioni, A. D., Meegalla, R. L., & Wilson, J. M. (1999) · Infection and Immunity · doi:10.1128/iai.67.11.6084-6089.1999 · Cited by 302
Mouse macrophages synthesize and secrete a protein resembling apolipoprotein E.
Basu, S. K., Brown, M. S., Ho, Y. K., Havel, R. J., & Goldstein, J. L. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.12.7545 · Cited by 300
Tumor necrosis factor and the acute metabolic response to tissue injury in man.
Starnes, H. F., Warren, R. S., Jeevanandam, M., Gabrilove, J. L., Larchian, W., Oettgen, H. F., & Brennan, M. F. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113733 · Cited by 300
CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide.
Ingalls, R. R., & Golenbock, D. T. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.4.1473 · Cited by 293
Cutting Edge: Immune Stimulation by Neisserial Porins Is Toll-Like Receptor 2 and MyD88 Dependent
Massari, P., Henneke, P., Ho, Y., Latz, E., Golenbock, D. T., & Wetzler, L. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1533 · Cited by 292
Bosisio, D., Polentarutti, N., Sironi, M., Bernasconi, S., Miyake, K., Webb, G. R., Martin, M. U., Mantovani, A., & Muzio, M. (2002) · Blood · doi:10.1182/blood.v99.9.3427 · Cited by 290
Ulevitch, R. J., Johnston, A. R., & Weinstein, D. B. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109610 · Cited by 290
Hickey, M. J., Sharkey, K. A., Sihota, E. G., Reinhardt, P. H., Macmickeng, J. D., Nathan, C., & Kubes, P. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.12.9337148 · Cited by 288
Stimulation of monokine production by lipoteichoic acids
Bhakdi, S., Klonisch, T., Nuber, P., & Fischer, W. (1991) · Infection and Immunity · doi:10.1128/iai.59.12.4614-4620.1991 · Cited by 286
Wright, S. D., Ramos, R. A., Hermanowski-Vosatka, A., Rockwell, P., & Detmers, P. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.5.1281 · Cited by 285
Thomas, C. A., Li, Y., Kodama, T., Suzuki, H., Silverstein, S. C., & El Khoury, J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.1.147 · Cited by 282
van der Laan, L. J. W., Döpp, E. A., Haworth, R., Pikkarainen, T., Kangas, M., Elomaa, O., Dijkstra, C. D., Gordon, S., Tryggvason, K., & Kraal, G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.939 · Cited by 280
Hack, C. E., Aarden, L. A., & Thus, L. G. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60597-0 · Cited by 280
Matsuguchi, T., Musikacharoen, T., Ogawa, T., & Yoshikai, Y. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5767 · Cited by 278
The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments.
Innerarity, T. L., Friedlander, E. J., Rall, S. C., Weisgraber, K. H., & Mahley, R. W. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44180-9 · Cited by 276 · cited 1×
“Thrombin digestion of ApoE yields two fragments, of which the 10-kDa C-terminal fragment harbors the lipid-binding domain whereas the LDL receptor (LDLr)-binding domain is situated in the 22-kDa N-terminal fragment (235, 581).”
BackgroundHaworth, R., Platt, N., Keshav, S., Hughes, D., Darley, E., Suzuki, H., Kurihara, Y., Kodama, T., & Gordon, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1431 · Cited by 274
Iwami, K.-I., Matsuguchi, T., Masuda, A., Kikuchi, T., Musikacharoen, T., & Yoshikai, Y. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.6682 · Cited by 273
IL-1 induction-capacity of defined lipopolysaccharide partial structures.
Loppnow, H., Brade, H., Dürrbaum, I., Dinarello, C. A., Kusumoto, S., Rietschel, E. T., & Flad, H. D. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.9.3229 · Cited by 270
Scott, M. G., Vreugdenhil, A. C. E., Buurman, W. A., Hancock, R. E. W., & Gold, M. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.549 · Cited by 270
Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells.
Kawakami, M., Pekala, P. H., Lane, M. D., & Cerami, A. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.3.912 · Cited by 267
Wurfel, M. M., Hailman, E., & Wright, S. D. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1743 · Cited by 267
Angus, D. C. (2000) · JAMA · doi:10.1001/jama.283.13.1723 · Cited by 266
Evidence for an Accessory Protein Function for Toll-Like Receptor 1 in Anti-Bacterial Responses
Wyllie, D. H., Kiss-Toth, E., Visintin, A., Smith, S. C., Boussouf, S., Segal, D. M., Duff, G. W., & Dower, S. K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.7125 · Cited by 266
Clinical Gram-positive sepsis: Does it fundamentally differ from Gram-negative bacterial sepsis?
Opal, S. M., & Cohen, J. (1999) · Critical Care Medicine · doi:10.1097/00003246-199908000-00039 · Cited by 259
Lipopolysaccharide (LPS) Signal Transduction and Clearance
Gegner, J. A., Ulevitch, R. J., & Tobias, P. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5320 · Cited by 256
Wright, S. D., Levin, S. M., Jong, M. T., Chad, Z., & Kabbash, L. G. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.175 · Cited by 256
Astiz, M. E., & Rackow, E. C. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01134-9 · Cited by 255
Gazzano-Santoro, H., Parent, J. B., Grinna, L., Horwitz, A., Parsons, T., Theofan, G., Elsbach, P., Weiss, J., & Conlon, P. J. (1992) · Infection and Immunity · doi:10.1128/iai.60.11.4754-4761.1992 · Cited by 254
Labéta, M. O., Vidal, K., Nores, J. E. R., Arias, M., Vita, N., Morgan, B. P., Guillemot, J. C., Loyaux, D., Ferrara, P., Schmid, D., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.10.1807 · Cited by 254
Why immunomodulatory therapies have not worked in sepsis
Abraham, E. (1999) · Intensive Care Medicine · doi:10.1007/s001340050903 · Cited by 252
Elass-Rochard, E., Roseanu, A., Legrand, D., Trif, M., Salmon, V, Motas, C., Montreuil, J., & Spik, G. (1995) · Biochemical Journal · doi:10.1042/bj3120839 · Cited by 251
Lee, J. D., Kato, K., Tobias, P. S., Kirkland, T. N., & Ulevitch, R. J. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.6.1697 · Cited by 251
Apolipoprotein E and atherosclerosis
Curtiss, L. K., & Boisvert, W. A. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200006000-00004 · Cited by 251
Biochemical characterization of a soluble form of the 53‐kDa monocyte surface antigen
Bažil, V., Hořejší, V., Baudyš, M., Krištofová, H., Strominger, J. L., Kostka, W., & Hilgert, I. (1986) · European Journal of Immunology · doi:10.1002/eji.1830161218 · Cited by 246
Doi, T., Higashino, K., Kurihara, Y., Wada, Y., Miyazaki, T., Nakamura, H., Uesugi, S., Imanishi, T., Kawabe, Y., & Itakura, H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53971-5 · Cited by 243
Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3.
Weisgraber, K. H., Rall, S. C., Mahley, R. W., Milne, R. W., Marcel, Y. L., & Sparrow, J. T. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35898-2 · Cited by 240
Kengatharan, K. M., De Kimpe, S., Robson, C., Foster, S. J., & Thiemermann, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.305 · Cited by 238
Elsbach, P., Weiss, J., Franson, R. C., Beckerdite-Quagliata, S., Schneider, A., & Harris, L. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86622-x · Cited by 235
Peiser, L., Gough, P. J., Kodama, T., & Gordon, S. (2000) · Infection and Immunity · doi:10.1128/iai.68.4.1953-1963.2000 · Cited by 235
Signaling Events Induced by Lipopolysaccharide-Activated Toll-Like Receptor 2
Yang, R.-B., Mark, M. R., Gurney, A. L., & Godowski, P. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.639 · Cited by 234
Seki, E., Tsutsui, H., Nakano, H., Tsuji, N. M., Hoshino, K., Adachi, O., Adachi, K., Futatsugi, S., Kuida, K., Takeuchi, O., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2651 · Cited by 231
The Toll-like Receptor Protein Rp105 Regulates Lipopolysaccharide Signaling in B Cells
Ogata, H., Su, I.-H., Miyake, K., Nagai, Y., Akashi, S., Mecklenbräuker, I., Rajewsky, K., Kimoto, M., & Tarakhovsky, A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.1.23 · Cited by 230
Toll-like Receptor-2 Mediates Treponema Glycolipid and Lipoteichoic Acid-induced NF-κB Translocation
Opitz, B., Schröder, N. W. J., Spreitzer, I., Michelsen, K. S., Kirschning, C. J., Hallatschek, W., Zähringer, U., Hartung, T., Göbel, U. B., & Schumann, R. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010481200 · Cited by 228
Kotani, S., Takada, H., Tsujimoto, M., Ogawa, T., Takahashi, I., Ikeda, T., Otsuka, K., Shimauchi, H., Kasai, N., & Mashimo, J. (1985) · Infection and Immunity · doi:10.1128/iai.49.1.225-237.1985 · Cited by 226
Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids.
Yu, B., Hailman, E., & Wright, S. D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119160 · Cited by 225
Endotoxin-induced cytokine gene expression and excretion in the liver
Luster, M. I., Germolec, D. R., Yoshida, T., Kayama, F., & Thompson, M. (1994) · Hepatology · doi:10.1002/hep.1840190229 · Cited by 224
Weiss, J., Elsbach, P., Shu, C., Castillo, J., Grinna, L., Horwitz, A., & Theofan, G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115930 · Cited by 224
Mathison, J. C., Tobias, P. S., Wolfson, E., & Ulevitch, R. J. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.1.200 · Cited by 223
The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding.
Weisgraber, K. H., Innerarity, T. L., Harder, K. J., Mahley, R. W., Milne, R. W., Marcel, Y. L., & Sparrow, J. T. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44181-0 · Cited by 220 · cited 1×
“Thrombin digestion of ApoE yields two fragments, of which the 10-kDa C-terminal fragment harbors the lipid-binding domain whereas the LDL receptor (LDLr)-binding domain is situated in the 22-kDa N-terminal fragment (235, 581).”
BackgroundSchumann, R. R., Kirschning, C. J., Unbehaun, A., Aberle, H., Knopf, H.-P., Lamping, N., Ulevitch, R. J., & Herrmann, F. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3490 · Cited by 217
Cell biology of liver endothelial and Kupffer cells.
Smedsrød, B., De Bleser, P. J., Braet, F., Lovisetti, P., Vanderkerken, K., Wisse, E., & Geerts, A. (1994) · Gut · doi:10.1136/gut.35.11.1509 · Cited by 216
Human Monocytes/Macrophages Release TNF-α in Response to Ox-LDL
Jovinge, S., Ares, M. P. S., Kallin, B., & Nilsson, J. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.12.1573 · Cited by 216
Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon
Heinzel, F. P., Rerko, R. M., Ling, P., Hakimi, J., & Schoenhaut, D. S. (1994) · Infection and Immunity · doi:10.1128/iai.62.10.4244-4249.1994 · Cited by 215
Haziot, A., Tsuberi, B. Z., & Goyert, S. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.12.5556 · Cited by 214
Harris, H. W., Grunfeld, C., Feingold, K. R., Read, T. E., Kane, J. P., Jones, A. L., Eichbaum, E. B., Bland, G. F., & Rapp, J. H. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116259 · Cited by 214
Dabbagh, K., Dahl, M. E., Stepick-Biek, P., & Lewis, D. B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4524 · Cited by 212
Parker, T. S., Levine, D. M., Chang, J. C., Laxer, J., Coffin, C. C., & Rubin, A. L. (1995) · Infection and Immunity · doi:10.1128/iai.63.1.253-258.1995 · Cited by 211
Ji, Z. S., Fazio, S., Lee, Y. L., & Mahley, R. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42009-6 · Cited by 210
The Primary Role of Lymphoreticnlar Cells in the Mediation of Host Responses to Bacterial Endotoxim
Michalek, S. M., Moore, R. N., McGhee, J. R., Rosenstreich, D. L., & Mergenhagen, S. E. (1980) · Journal of Infectious Diseases · doi:10.1093/infdis/141.1.55 · Cited by 210
de Bont, N., Netea, M. G., Demacker, P. N. M., Verschueren, I., Kullberg, B. J., van Dijk, K. W., van der Meer, J. W. M., & Stalenhoef, A. F. H. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32147-7 · Cited by 210
Rosenberger, C. M., Scott, M. G., Gold, M. R., Hancock, R. E. W., & Finlay, B. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5894 · Cited by 209
Role for circulating lipoproteins in protection from endotoxin toxicity
Feingold, K. R., Funk, J. L., Moser, A. H., Shigenaga, J. K., Rapp, J. H., & Grunfeld, C. (1995) · Infection and Immunity · doi:10.1128/iai.63.5.2041-2046.1995 · Cited by 209
Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide.
Ferrero, E., Jiao, D., Tsuberi, B. Z., Tesio, L., Rong, G. W., Haziot, A., & Goyert, S. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2380 · Cited by 208
Netea, M. G., Demacker, P. N., Kullberg, B. J., Boerman, O. C., Verschueren, I., Stalenhoef, A. F., & van der Meer, J. W. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118556 · Cited by 207
Surfactant Proteins A and D Bind CD14 by Different Mechanisms
Sano, H., Chiba, H., Iwaki, D., Sohma, H., Voelker, D. R., & Kuroki, Y. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001107200 · Cited by 205
Dephosphorylation of endotoxin by alkaline phosphatase in vivo.
Poelstra, K., Bakker, W. W., Klok, P. A., Kamps, J. A. A. M., Hardonk, M., & Meijer, D. K. F. (1997) · Europe PMC (PubMed Central) · Cited by 204
Wang, J. E., Jørgensen, P. F., Almlöf, M., Thiemermann, C., Foster, S. J., Aasen, A. O., & Solberg, R. (2000) · Infection and Immunity · doi:10.1128/iai.68.7.3965-3970.2000 · Cited by 204
Cited by
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650
“( B ) Hep3B cells: untreated (0), treated for 24 hours with 16.6% medium from monocyte-derived macrophages ( n = 2 donors) or Kupffer cells ( n = 2 donors) either unstimulated (M) or stimulated with 100 ng/ml LPS (M-LPS) or treated for 24 hours with the same 16.6% M-LPS + 6 μ g/ml anti–IL-6 Ab's (M-LPS + IL-6 Ab's).”
InfluentialMACROPHAGE RECEPTORS AND IMMUNE RECOGNITION
Taylor, P. R., Martinez-Pomares, L., Stacey, M., Lin, H.-H., Brown, G. D., & Gordon, S. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115816 · Cited by 1,324
Bates, J. M., Akerlund, J., Mittge, E., & Guillemin, K. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.10.010 · Cited by 751
Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications
Kanoh, S., & Rubin, B. K. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00078-09 · Cited by 708
Becker, K. L., Nylén, E. S., White, J. C., Müller, B., & Snider, R. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021444 · Cited by 578
Metadata
- Authors
- Van Amersfoort, E. S., Van Berkel, T. J. C., & Kuiper, J.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2003-07
- Volume
- 16
- Issue
- 3
- Pages
- 379-414
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2131392583
- Cited by
- 750
- References
- 531
- FWCI
- 12.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.